Kyoto University
Department of Early Clinical Development Graduate School of MedicineKyoto University HospitalDepartment of Early Clinical DevelopmentKyoto Innovation Center for Next Generation Clinical Trials and iPS Cell Therapy (Ki-CONNECT)
April 2022 to March 2024 Takeshi Sawada (Principal Investigator) is implementing the project (Grants-in-Aid for Young Scientists(MEXT)“Study on mitochondrial DNA in cancer cells using mitochondrial DNA repraced cells”
April 2022 to March 2025 Masahiko Aoki (Principal Investigator) is implementing the project (Grants-in-Aid for young Scientists(MEXT))“Establishment of new drug sensitivity test using patient-derived cancer organoids from CTOS method”
Next Generation Medical and iPS Cell Therapy Research Center (Ki-CONNECT) Early Medical Development Department A new specific lecturer, Sawada, has been appointed.
October 2021 to March 2024 Takeshi Sawada (Principal Investigator) is implementing the project (Japan Agency for Medical Research and Development)“Development of ex vivo safety/efficacy evaluation method for GPC-1 CAR T therapy for solid tumors”
Next Generation Medical and iPS Cell Therapy Research Center(Ki-CONNECT) Early Medical Development Department Assistant professor, Masahiko Aoki has been appointed.
« 過去の投稿
新しい投稿 »